Proteasome inhibition induces a senescence-like phenotype in primary human fibroblasts cultures

Biogerontology

Volumn 5, Issue 1, 2004, Pages 55-61

  Chondrogianni, Niki ^a   Gonos, Efstathios S ^a  

^a INSTITUTE OF BIOLOGY   (Greece)

Author keywords

Ageing; Epoxomicin; Human fibroblasts; MG132; Proteasome inhibition; Senescence

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; BETA GALACTOSIDASE; CELL PROTEIN; CHYMOTRYPSIN; EPOXOMICIN; HYDROLASE; PROTEASOME; PROTEASOME INHIBITOR;

ARTICLE; CELL AGING; CELL DIVISION; CELL LINE; CHEMICAL ANALYSIS; CONTROLLED STUDY; EMBRYO; ENZYME INHIBITION; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; STAINING;

BETA-GALACTOSIDASE; CELL AGING; CELL DIVISION; CELL LINE; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; ENDOPEPTIDASES; FIBROBLASTS; HUMANS; LEUPEPTINS; MULTIENZYME COMPLEXES; OLIGOPEPTIDES; PEPTIDE HYDROLASES; PHENOTYPE; PROTEASOME ENDOPEPTIDASE COMPLEX;

EID: 1842789948     PISSN: 13895729     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:BGEN.0000017687.55667.42     Document Type: Article

References (26)

1. Brooks P, Murray RZ, Mason GG, Hendil KB and Rivett AJ (2000) Association of immunoproteasomes with the endoplasmic reticulum. Biochem J 352: 611-615
2. Bulteau AL, Petropoulos I and Friguet B (2000) Age-related alterations of proteasome structure and function in aging epidermis. Exp Gerontol 35: 767-777
3. Bulteau AL, Szweda LI and Friguet B (2002) Age-dependent declines in proteasome activity in the heart. Arch Biochem Biophys 397: 298-304
4. Campisi J (2001) From cells to organisms: Can we learn about aging from cells in culture? Exp Gerontol 36: 607-618
5. Chondrogianni N, Petropoulos I, Franceschi C, Friguet B and Gonos ES (2000) Fibroblasts cutures from healthy centenarians have an active proteasome. Exp Gerontol 35: 721-728
6. Chondrogianni N, Fragoulis EG and Gonos ES (2002) Protein degaradation during aging: The lysosome-, the calpain- and the proteasome-dependent cellular proteolytic systems. Biogerontology 3: 121-123
7. Chondrogianni N, Stratford FLL, Trougakos IP, Friguet B, Rivett AJ and Gonos ES (2003) Central role of the proteasome in senescence and survival of human fibroblasts: Induction of a senescence-like phenotype upon its inhibition and resistance to stress upon its activation. J Biol Chem 278: 28026-28037
8. Davies KJ (1999) The broad spectrum of responses to oxidants in proliferating cells: A new paradigm for oxidative stress. IUBMB Life 48: 41-47
9. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubel I, Pereira-Smith O, Peacocke M and Campisi J (1995) A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 92: 9363-9367
10. Franco S, MacKenzie KL, Dias S, Alvarez S, Rafii S and Moore MAS (2001) Clonal variation in phenotype and lifespan of human embryonic fibroblasts (MRC-5) transduced with the catalytic component of telomerase (hTERT). Exp Cell Res 268: 14-25
11. Fonager J, Beedholm R, Clark BF and Rattan SIS (2002) Mild stress-induced stimulation of heat-shock protein synthesis and improved functional ability of human fibroblasts undergoing aging in vitro. Exp Gerontol 37: 1223-1228
12. Gaczynska M, Osmulski PA and Ward WF (2001) Caretaker or undertaker? The role of the proteasome in aging. Mech Ageing Dev 122: 235-254
13. Harlow E and Lane D (1999) Using Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York
14. Hendil KB, Kristensen P and Uerkvitz W (1995) Human proteasomes analysed with monoclonal antibodies. Biochem J 305: 245-252
15. Kikuchi S, Shinpo K, Takeuchi M, Yamagishi S, Makita Z, Sasaki N and Tashiro K (2003) Glycation: A sweet tempter for neuronal death. Brain Res Brain Res Rev 41: 306-323
16. Lee DH and Goldberg AL (1998) Proteasome inhibitors: Valuable new tools for cell biologists. Trends Cell Biol 8: 397-403
17. Merker K and Grune T (2000) Proteolysis of oxidised proteins and cellular senescence. Exp Gerontol 35: 779-786
18. Merker K, Sitte N and Grune T (2000) Hydrogen peroxide-mediated protein oxidation in young and old human MRC-5 fibroblasts. Arch Biochem Biophys 375: 50-54
19. Petropoulos I, Conconi M, Wang X, Hoenel B, Brégègére F and Friguet B (2000) Increase of oxidatively modified protein is associated with decrease of proteasome activity and content in aging epidermal cells. J Gerontol Biol Sci Med Sci 55: B220-B227
20. Rattan SIS (2001) Applying hormesis in aging research and therapy. Hum Exp Toxicol 20: 281-285
21. Serra V, von Zglinicki T, Lorenz M and Saretzki G (2003) Extracellular superoxide dismutase is a major antioxidant in human fibroblasts and slows telomere shortening. J Biol Chem 278: 6824-6830
22. Sin N, Kim KB, Elofsson M, Meng L, Auth H, Kwok BH and Crews CM (1999) Total synthesis of the potent proteasome inhibitor epoxomicin: a useful tool for understanding proteasome biology. Bioorg Med Chem Lett 9: 2283-2288
23. Sitte N, Merker K, von Zglinicki T, Grune T and Davies KJA (2000a) Protein oxidation and degradation during cellular senescence of human BJ fibroblasts: Part I - effects of proliferative senescence. FASEB J 14: 2495-2502
24. Sitte N, Merker K, von Zglinicki T, Grune T and Davies KJA (2000b) Protein oxidation and degradation during cellular senescence of human BJ fibroblasts: Part II - aging of nondividing cells. FASEB J 14: 2503-2510
25. Sitte N, Merker K, von Zglinicki T and Grune T (2000c) Protein oxidation and degradation during proliferative senescence of human MRC-5 fibroblasts. Free Radic Biol Mexi 28: 701-708
26. Tsubuki S, Saito Y, Tomioka M, Ito H and Kawashima S (1996) Differential inhibition of calpain and proteasome activities by peptidyl aldehydes of di-leucine and tri-leucine. J Biochem 119: 572-576